Cancer Research

What Are the Risks of Brain-First Breast Cancer Recurrence?
Research & Development What Are the Risks of Brain-First Breast Cancer Recurrence?

Modern adjuvant protocols have pushed the overall ten-year survival rate to 78.3%, highlighting the specific gravity of the minority who suffer CNS relapses. Despite significant breakthroughs in systemic treatments that effectively clear cancer cells from the rest of the body, the central nervous

The Evolution and Impact of Breast MRI in Modern Oncology
Tech & Innovation The Evolution and Impact of Breast MRI in Modern Oncology

The emergence of contrast-enhanced MRI provides a level of diagnostic granularity that is particularly critical for patients who have a significant family history of disease. For decades, the global medical community relied almost exclusively on mammography as the cornerstone of early cancer

Can Citrus Peel Nanoparticles Kill Cervical Cancer Cells?
Research & Development Can Citrus Peel Nanoparticles Kill Cervical Cancer Cells?

Experimental data shows that these citrus-derived nanoparticles exhibit pH-responsive release, discharging eighty percent of their payload in acidic environments similar to tumor microenvironments. This precision delivery mechanism represents a significant leap forward in addressing the persistent

Are Piezoelectric Nanozymes the Future of Cancer Therapy?
Research & Development Are Piezoelectric Nanozymes the Future of Cancer Therapy?

Current clinical advancements in nanomedicine prioritize the development of materials that can unmask tumor antigens to the immune system through precise cell lysis. This strategic shift reflects a broader recognition that conventional treatments like chemotherapy often falter because they cannot

FAU Researchers Use Quantum AI to Predict Lung Cancer Cases
Tech & Innovation FAU Researchers Use Quantum AI to Predict Lung Cancer Cases

The persistence of environmental noise and decoherence remains a primary technical hurdle when transitioning quantum diagnostic models from simulations to physical processors. Florida Atlantic University (FAU) researchers have successfully navigated these complexities to achieve a significant

Can mRNA Monobodies Treat Undruggable Cancers?
Tech & Innovation Can mRNA Monobodies Treat Undruggable Cancers?

Transcription factors act as biological switches that, when stuck in the 'on' position, trigger the rapid and unregulated cell division characteristic of malignant tumors. For decades, these pivotal components of cellular machinery have remained largely out of reach for modern pharmacology, leading

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later